Cantargia announces full recruitment of CAN04 monotherapy arm in ongoing phase IIa clinical trial

Image: The CAN04 is examined as monotherapy or in chemotherapy combinations in patients with non-small cell lung cancer or pancreatic cancer. Photo: courtesy of PublicDomainPictures from Pixabay.